22 dec: BICHELS WEEKENDHAPSERE - OGSÅ I JULEN
23 dec: Top 3 på teamudvikling
22-12-2010 16:57:00

Briscoe Law Firm Investigates Martek Biosciences for Shareholders

The

Briscoe Law Firm, PLLC, founded by a former state prosecutor and

enforcement attorney for the United States Securities and Exchange

Commission, and the law firm of Powers

Taylor LLP are investigating the fairness of the proposed

acquisition of Martek

Biosciences Corporation (“Martek Biosciences” or “MATK”) (NASDAQ:

MATK) by Royal DSM N.V. (“DSM”) for shareholders. The investigation

relates to possible breaches of fiduciary duty and other violations of

state law by the Board of Directors of Martek Biosciences for approving

this transaction, whether Martek Biosciences’ Board of Directors acted

in the shareholders’ best interests, and whether the transaction

provides fair value and adequate disclosures to the shareholders.

The definitive acquisition agreement, which was announced on December

21, 2010, involves an all-cash tender offer valued at approximately

$1.09 billion that is expected to commence in January 2011 and close in

February 2011. Under the proposed acquisition, Martek Biosciences

shareholders will receive a cash payment of only $31.50 for each share

of Martek Biosciences/MATK common stock they hold. While the acquisition

price reportedly represents an approximate 35% premium over Martek

Biosciences’ closing price the day before the acquisition announcement,

Martek Biosciences recently reported strong fourth quarter results,

including a 36% increase in revenue growth, well above analysts’

estimates, and operational improvements. Based on this and other

factors, the firms believe that the acquisition price significantly

undervalues the company and may not be fair to Martek Biosciences

shareholders.

If you currently own shares of Martek Biosciences/MATK and would like

additional information regarding this investigation, or if you have

information regarding the allegations involved in this transaction,

please contact Patrick Powers at Powers Taylor LLP, toll free (877)

728-9607, via e-mail at patrick@powerstaylor.com,

or Willie Briscoe at The Briscoe Law Firm, PLLC toll free (877)

397-5991, or via email at WBriscoe@TheBriscoeLawFirm.com.

There is no cost or fee to you.

The Briscoe Law Firm is a full service business litigation and

shareholder rights advocacy firm with more than 20 years of experience

in complex litigation and transactional matters.

Powers Taylor LLP is a boutique litigation law firm that handles a

variety of complex business litigation matters, including claims of

investor and stockholder fraud, shareholder oppression, shareholder

derivative suits, and security class actions.

Powers Taylor LLP

Patrick Powers, 877-728-9607

patrick@powerstaylor.com

or

The

Briscoe Law Firm, PLLC

Willie Briscoe, 877-397-5991

WBriscoe@TheBriscoeLawFirm.com

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
24 aug
FING-B
Sig mig.. har du slet ingen skam i livet !!.. du stjæler ENDNU ENGANG et skriv fra en anden skribent..
22
23 aug
BAVA
Bavarian Nordic har sammen med Crucell og div. myndigheder igangsat to interessante nye forsøg med M..
18
20 aug
MAERSK-B
Jeg har gravet mig ind i 6-8 oil projekter, der vil tjene Maersk Oil fra 2016 og frem, og Johan Sver..
17
24 aug
ZEAL
I Solothum uden for Bern i Svejts ligger en fabrik, hvor der er blevet investeret 50 mio CHF det sen..
16
21 aug
ZEAL
Bølgerne har gået højt her på EI’s forum siden Sanofi fredag oplyst at et mere endeligt svar på sags..
15
23 aug
DANSKE
Tro ikke på 6212 han er blot en bondeknold, der efterhånden er gået kold arme stakkels lille trold, ..
14
23 aug
 
http://borsen.dk/nyheder/politik/artikel/1/330221/opgoerelse_viser_nye_milliarder_tabt_til_skattesvi..
13
19 aug
GEN
jeg HAR selv Genmab - så er det på plads.   -------------------   Ganske kort mener jeg noget i stil..
13
24 aug
GEN
Patientgrundlaget er vurderet til at være ca. 20.000 patienter i US plus de 5 største lande i EU for..
12
23 aug
HMGLF
Baggrund:Prisen på kontrakt-lithium har været jævnt stigende i mindst 10 år, men i Kina steg spotpri..
11

Glunz FY: Ingen udbytte i vente efter ventet underskud

25-08-2016 15:09:39
Der var underskud på bundlinjen for Glunz & Jensen, der blandt andet laver og sælger udstyr til trykkerier, i det netop overståede regnskabsår, der løb fra 1. j..

Alm. Brand/CEO: Tre årsager til samlet opjustering

25-08-2016 13:00:16
Alm. Brand-koncernen kunne i torsdag morgens regnskab for andet kvartal opjustere forventningerne til hele årets resultat før skat med 100 mio. kr.Langt største..

ATP/CEO: Dong Energy skæppede med 2,9 mia. kr. - NY

25-08-2016 11:06:43
Pensionsgiganten ATP fik i første halvår et investeringsafkast på 6,7 pct. svarende til 6,9 mia. kr. Mens man tabte på udenlandske aktier - de japanske især - s..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Zealand H1: Venter bedste år nogensinde med bredere portefølje
2
Aktier/tendens: Strøm af regnskaber ventes at dominere
3
Torsdagens aktier: Pandora på pinebænken efter USA-skuffelse
4
Parken/Nordnet: Aktien kan stige tocifret efter opjustering
5
Aktier/middag: Regnskabsvrimmel med plus til Sydbank

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. august 2016 22:09:32
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160823.1 - EUROWEB4 - 2016-08-25 22:09:32 - 2016-08-25 22:09:32 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x